CD274 and cancer: Therefore, although plasma EBV DNA level correlated with higher rates of recurrence and metastasis and lower OS in NPC, it may be associated with better efficacy of pembrolizumab, as this drug allows the recognition of cancer cells despite PD-L1 upregulation (17, 18).